![]() ![]() Triarco Industries in its sale to Innophos.The United States Department of the Treasury in the management of its $250 billion TARP Capital Purchase Program.Élan in the $3.25 billion sale of its interest in TYSABRI to Biogen Idec.Dell’s financial advisor in connection with its $24.9 billion acquisition by Michael Dell and Silver Lake Partners.Air Products and Chemicals in its agreement with Pershing Square Capital Management following the 9.8% investment position taken by Bill Ackman.Bank’s financial advisor in connection with its agreement to acquire Eddie Bauer and its subsequent sale to Men’s Wearhouse Cigna Corporation in connection with the public offering of $900 million of 3.250% Senior Notes due 2025.Medifast in its agreement with Engaged Capital.The Pasha Group in its acquisition of the Hawaii trade-lane business of Horizon Lines.in its proxy contest and related litigation against activist hedge fund Sessa Capital, which sought unsuccessfully to replace a majority of the company’s board Mantle Ridge LP in its investment in CSX Corporation and successful effort to install Hunter Harrison as the company’s CEO and to add five new directors, including Paul Hilal and Harrison, to the company’s board. ![]() Investors Nathan Miller and Peter O’Malley in their successful effort to replace the entire board of directors of Destination Maternity Corporation with a majority-female slate.SRS Investment Management in the renewal of its cooperation agreement with Avis Budget Group, Inc.The Howard Hughes Corporation in a Rule 144A/Reg S offering of $750 million aggregate principal amount of 5.375% senior notes.and its successful effort to add eight new directors, including Hudson Executive founder Douglas Braunstein, to the company’s board Hudson Executive Capital in its proxy contest and related litigation with USA Technologies Inc.Inteva Products in the sale of its roof systems design and assembly business to CIE Automotive.in the $167.5 million sale of its NAMIC® fluid management portfolio to Medline Industries, Inc. Monocle Acquisition Corporation in its merger with AerSale Corp.Hudson Executive Capital in its agreement, along with Apollo Global Management, to acquire Cardtronics plc for $2.3 billion.Ashford Hospitality Trust in its successful defense against an activist campaign by Cygnus Capital and related litigation that resulted in the withdrawal by Cygnus of all of its director nominations for election at the company’s annual meeting.through a Bankruptcy Code Section 363 asset sale and a joint venture acquisition vehicle majority owned by MBIA and Bardin Hill Investment Partners in connection with the acquisition of aircraft manufacturer MD Helicopters, Inc. and successful effort to appoint two directors to the company’s board Hudson Executive Capital LP in its investment in eHealth, Inc.and successful effort to add seven new directors, including Paul Hilal, to the company’s board and install Rick Dreiling as executive chairman Mantle Ridge LP in its investment in Dollar Tree, Inc.(NYSE: TWO) and wholly owned subsidiary Matrix Financial Services Corporation in Matrix's definitive agreement to acquire RoundPoint Mortgage Servicing Corporation from Freedom Mortgage Corporation ![]() ![]() in the $100 million sale of its Dialysis product portfolio and BioSentry Tract Sealant System Biopsy product to Merit Medical Systems, Inc. District Court for the Eastern District of New York. District Court for the Southern District of New York and the U.S. Braden McCurrach is admitted to practice law in the State of New York as well as in the U.S. from the University of Michigan Law School. Recently named a “Key Individual” for his work in M&A: Large Deals by The Legal 500 US, Braden also has been recognized from 2013-2019 by Super Lawyers as a New York Metro mergers and acquisitions “Rising Star.” He received his A.B. Braden also advises clients on complex transactions involving distressed companies and assets, including mergers, acquisitions, investments and financings, as well as restructurings. In addition to his transactional experience, Braden advises clients in a wide array of governance, securities and other commercial matters, including directors’ duties and responsibilities, board composition, disclosure issues and compliance. Braden’s practice also includes the representation of investment banks in their capacity as financial advisors on M&A and other transactions. His practice involves counseling clients in a broad range of transactional matters, including public and private mergers, acquisitions, divestitures, proxy contests, tender offers, spinoffs and joint ventures. Braden McCurrach is a partner in Cadwalader’s Corporate Group. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |